EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.
Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.
EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.
Contact:
EOS Med Chem, Medicinal Chemical is Big
執大象，天下往，往而無害，安平泰
Ms Nina
Youtube: https://youtu.be/r5cJdXKNXHk
Tel: 0086-531-69905422
SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China
N-[3-(2-aminoethoxy)phenyl]-4-methoxybenzamide hydrochloride, CAS: 1281182-46-4, stock: 9.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈N₂O₃.HCl.
N-[3-(aminomethyl)phenyl]benzamide hydrochloride, CAS: 1423032-67-0, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄N₂O.HCl.
N-[3-[3-[4-[(Dimethylamino)methyl]phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]-3-(trifluoromethyl)benzamide, CAS: 950736-05-7, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₄F₃N₅O.
N-[4-(1-Cyano-1-methylethyl)-3-(3-pyridinyl)phenyl]-3,4-dimethoxybenzamide, CAS: 1067191-08-5, stock: 9.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃N₃O₃.
N-[4-(1-hydroxyethyl)phenyl]benzamide, CAS: 1156379-24-6, stock: 7.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅NO₂.
N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]benzamide, CAS: 313553-47-8, stock: 9.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆N₂OS.
N-[4-(2-Chloroacetyl)phenyl]benzamide, CAS: 853574-47-7, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂ClNO₂.
N-[4-(5-Cyclopropanecarboxamido-1h-Benzimidazol-2-Yl)Phenyl]Benzamide, CAS: 1261268-99-8, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₀N₄O₂.
N-[4-(Hydrazinocarbonyl)phenyl]benzamide, CAS: 146305-29-5, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃N₃O₂.
N-[4-Bromo-3,5-(bistrifluoromethyl)phenyl]-2-hydroxy-5-nitrobenzamide, CAS: /, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₇BrF₆N₂O₄.
N-[4-Bromo-3-(bistrifluoromethyl)phenyl]-2-hydroxy-5-nitrobenzamide, CAS: /, stock: 2.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈BrF₃N₂O₄.
N-[4-Chloro-2-(1H-pyrrol-2-ylcarbonyl)phenyl]benzamide, CAS: 1026942-59-5, stock: 8.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₃N₂O₂Cl.
N-[4-Chloro-3-(trifluoromethyl)phenyl]-2-hydroxy-5-nitrobenzamide, CAS: 1352440-75-5, stock: 3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈ClF₃N₂O₄.
N-[4-Chloro-3-(trifluoromethyl)phenyl]-2-propoxybenzamide, CAS: 709676-56-2, stock: 2.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅ClF₃NO₂.
N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-5-nitrobenzamide, CAS: /, stock: 7.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₈F₃N₃O₄.
N-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-chloromethyl Benzamide, CAS: 404844-11-7, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₀ClN₅O.
N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-4,5-dimethoxy-2-nitrobenzamide, CAS: 1024592-54-8, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₁N₃O₇.
N-[4-[[4-(Chloromethyl)benzoyl]amino]-2-methylphenyl]-4-(3-pyridyl)-2-pyrimidineamine, CAS: 796738-74-4, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₀ClN₅O.
N-[5-Chloro-4-(4-chlorobenzoyl)-2-methylphenyl]-2-hydroxy-3,5-diiodo-benzamide, CAS: 50274-07-2, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₃Cl₂I₂NO₃.
N-[9-(2-Hydroxyethyl)-9H-carbazol-3-yl]-2-(trifluoromethyl)benzamide, CAS: 1195786-61-8, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₇F₃N₂O₂.
N-[carbamothioyl(cyclopropyl)methyl]benzamide, CAS: 1354953-10-8, stock: 9.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄N₂OS.
N-[Cyano(cyclopropyl)methyl]benzamide, CAS: 1315368-09-2, stock: 8.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂N₂O.
N-[cyclopropyl(2H-1,2,3,4-tetrazol-5-yl)methyl]benzamide, CAS: 1315367-08-8, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃N₅O.
N-[[(5-Chloro-2,1,3-benzothiadiazol-4-yl)amino]thioxomethyl]benzamide, CAS: 1240668-22-7, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₉ClN₄OS₂.
N-[[4-[[(4-Amino[1,1’-biphenyl]-3-yl)amino]carbonyl]phenyl]methyl]carbamic Acid Methyl Ester, CAS: 1013330-79-4, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₁N₃O₃.
N-[[4-[[(4-Amino[1,1’-biphenyl]-3-yl)amino]carbonyl]phenyl]methyl]carbamic Acid Methyl Ester-d3, CAS: /, stock: 7.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈D₃N₃O₃.
N-{3-[(Chloroacetyl)amino]phenyl}benzamide, CAS: 1233188-83-4, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃N₂O₂Cl.
N-{4-[(Dimethylamino)methyl]phenyl}-4-fluorobenzamide, CAS: 1183655-01-7, stock: 1.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇N₂OF.
N-{4-[Acetyl(methyl)amino]phenyl}-3-aminobenzamide, CAS: 1020054-02-7, stock: 6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇N₃O₂.
N-{4-[Acetyl(methyl)amino]phenyl}-4-aminobenzamide, CAS: 1020054-21-0, stock: 9.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇N₃O₂.
N-{8-azabicyclo[3.2.1]octan-3-yl}-N-methylbenzamide hydrochloride, CAS: 1432681-61-2, stock: 2.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀N₂O.HCl.
N-{[4-(aminomethyl)-1,3-thiazol-2-yl]methyl}benzamide, CAS: 1376044-35-7, stock: 2.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃N₃OS.
N-{[4-(Chloromethyl)-1,3-thiazol-2-yl]methyl}benzamide Hydrochloride, CAS: 1171958-63-6, stock: 5.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁N₂OSCl • HCl.
N2-Benzoyl-5’-O-(4,4-dimethoxytrity1)-2’-O-(tert-butyl dimethylsilyl) 6-chloroguanosine 3’-O-(2-Cyanoethyl N,N-diisopropylphosphoramidite), CAS: /, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₆₅ClN₇O₈PSi.
N2-Benzoylguanosine, CAS: 3676-72-0, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇N₅O₆.
N4-Benzoyl-2’-O-methylcytidine, CAS: 52571-45-6, stock: 3.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉N₃O₆.
N4-Benzoylcytosine, CAS: 26661-13-2, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉N₃O₂.
N6-Benzoyladenosine, CAS: 4546-55-8, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇N₅O₅.
Namino-Benzoyl Alogliptin, CAS: /, stock: 9.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₅N₅O₃.
N’-Hydroxy-4-methylbenzenecarboximidamide, CAS: 19227-13-5, stock: 6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀N₂O.
NDMC101, CAS: 1308631-40-4, stock: 1.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉ClFNO₂.
Nemonapride, CAS: 75272-39-8, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆ClN₃O₂.
Neoantimycin, CAS: 22862-63-1, stock: 5.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₄₆N₂O₁₂.
Nexturastat A, CAS: 1403783-31-2, stock: 4.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃N₃O₃.
Nexturastat A-d5, CAS: /, stock: 3.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈D₅N₃O₃.
NG 25, CAS: 1315355-93-1, stock: 1.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₀F₃N₅O₂.
Niclosamide, CAS: 50-65-7, stock: 2.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈Cl₂N₂O₄.
Niclosamide Ethanolamine Salt, CAS: 1420-04-8, stock: 6.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈Cl₂N₂O₄ • C₂H₇NO.
Niclosamide-13C6, CAS: 1325559-12-3, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇¹³C₆H₈Cl₂N₂O₄.
Nilotinib, CAS: 641571-10-0, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₂F₃N₇O.
Nilotinib HCl Monohydrate, CAS: 2010997-67-6, stock: 4.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₂F₃N₇O • 2(HCl) • (H ₂O).
Nilotinib Hydrochloride, CAS: 923288-95-3, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₂F₃N₇O • (HCl).
Nilotinib Monohydrochloride Monohydrate, CAS: 923288-90-8, stock: 7.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₂F₃N₇O • (HCl) • (H ₂O).
Nilotinib N-Oxide, CAS: 1246817-85-5, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₂F₃N₇O₂.
Nilotinib Regio Isomer, CAS: 641571-15-5, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₂F₃N₇O.
Nilotinib-d3, CAS: 1215678-43-5, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₁₉D₃F₃N₇O.
Nilotinib-d6, CAS: 1268356-17-7, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₁₆D₆F₃N₇O.
Nitazoxanide, CAS: 55981-09-4, stock: 1.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉N₃O₅S.
Nitazoxanide-d4, CAS: 1246819-17-9, stock: 5.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₅D₄N₃O₅S.
Nα-Benzoyl-DL-arginine β-Naphthylamide Hydrochloride, CAS: 913-04-2, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₅N₅O₂•HCl.
Nα-Benzoyl-L-arginine 4-Nitroanilide Hydrochloride, CAS: 21653-40-7, stock: 2.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂N₆O₄•HCl.
Nα-Benzoyl-L-arginine-7-amido-4-methylcoumarin Hydrochloride, CAS: 83701-04-6, stock: 3.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₅N₅O₄•HCl.
Nor Cisapride Hydrochloride, CAS: 2124296-36-0, stock: 2.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁Cl₂N₃O₃.
Novaluron, CAS: 116714-46-6, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₉ClF₈N₂O₄.
Novaluron-13C6, CAS: /, stock: 3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁¹³C₆H₉ClF₈N₂O₄.
Novaluron-d3, CAS: /, stock: 7.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₆D₃ClF₈N₂O₄.
Novobiocin, CAS: 303-81-1, stock: 6.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₆N₂O₁₁.
Novobiocin Sodium Salt, CAS: 1476-53-5, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₅N₂NaO₁₁.
NSC 405020, CAS: 06/07/7497, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅Cl₂NO.
NU 6140, CAS: 444723-13-1, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀N₆O₂.
NVP-BHG712, CAS: 940310-85-0, stock: 6.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₀F₃N₇O.
NVP-TAE 226, CAS: 761437-28-9, stock: 4.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₅ClN₆O₃.
O-Acetylsalicylhydroxamic Acid, CAS: 199854-00-7, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉NO₄.
O-Des(2-dimethylaminoethyl)-O-methyl Itopride, CAS: 331239-23-7, stock: 1.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉NO₄.
O-Desmethyl Encainide, CAS: 81329-70-6, stock: 5.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆N₂O₂.
O-Desmethyl Metoclopramide Hydrochloride, CAS: 38059-78-8, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₁Cl₂N₃O₂.
o-Toluanilide, CAS: 7055-03-0, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃NO.
OAC1, CAS: 300586-90-7, stock: 4.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁N₃O.
Org 25543 Hydrochloride, CAS: 495076-64-7, stock: 10g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂N₂O₄ • HCl.
Orthosulfamuron, CAS: 213464-77-8, stock: 3.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀N₆O₆S.
Oxo-MDV 3100 (Oxo-enzalutamide), CAS: 1242137-18-3, stock: 8.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₆F₄N₄O₃.
Oxo-MDV 3100-d3 (Oxo-enzalutamide-d3), CAS: /, stock: 7.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₃D₃F₄N₄O₃.
Oxyclozanide, CAS: 2277-92-1, stock: 8.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₆Cl₅NO₃.
p-(Benzoylamino)benzoic Acid, CAS: 582-80-9, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁NO₃.
p-MPPF Hydrochloride, CAS: 223699-41-0, stock: 1.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇FN₄O₂ • x( HCl).
p-MPPI Monohydrochloride, CAS: 220643-77-6, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇IN₄O₂ •HCl.
p-[2-[(5-Chloro-2-methoxybenzoyl)amino]ethyl]benzenephosphonate, CAS: 594854-55-4, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇ClNO₆P.
PD 168077, CAS: 190383-31-4, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₂N₄O.
PD 198306, CAS: 212631-61-3, stock: 7.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆F₃IN₂O₂.
PD-184161, CAS: 212631-67-9, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₃BrClF₂IN₂O₂.
PD-184352, CAS: 212631-79-3, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄ClF₂IN₂O₂.
PD-325901, CAS: 391210-10-9, stock: 8.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄F₃IN₂O₄.
PF 429242, CAS: 947303-87-9, stock: 5.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₅N₃O₂.
PF-04929113 (Mesylate), CAS: 1173111-67-5, stock: 5.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₀F₃N₅O₄ • (CH ₄O₃S).
PFI-4, CAS: 900305-37-5, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄N₄O₃.
PFI-4-d6, CAS: /, stock: 5.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈D₆N₄O₃.
PG01037 Dihydrochloride, CAS: 675599-62-9, stock: 4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₆Cl₂N₄O •2HCl.
PH-797804, CAS: 586379-66-0, stock: 5.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉BrF₂N₂O₃.
PH-797804-d5, CAS: /, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₄D₅BrF₂N₂O₃.
Phenyl 4-Bromo-2-ethoxybenzamide, CAS: 1261918-68-6, stock: 4.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄NO₂Br.
Piclamilast, CAS: 144035-83-6, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈Cl₂N₂O₃.
Pluripotin, CAS: 839707-37-8, stock: 5.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₅F₃N₈O₂.
Pluripotin-d3, CAS: /, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₂D₃F₃N₈O₂.
PND-1186, CAS: 1061353-68-1, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆F₃N₄O₃.
PNU 282987, CAS: 123464-89-1, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇ClN₂O • HCl.
PNU-282987, CAS: 711085-63-1, stock: 9.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇ClN₂O.
Ponatinib, CAS: 943319-70-8, stock: 6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₇F₃N₆O.
Ponatinib Glucuronide, CAS: /, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₆F₃N₆O₇⁺.
Ponatinib N-Oxide, CAS: /, stock: 6.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₇F₃N₆O₂.
Ponatinib-d8, CAS: /, stock: 2.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₁₉D₈F₃N₆O.
Pranlukast, CAS: 103177-37-3, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₃N₅O₄.
Pranlukast-d5, CAS: 1216719-50-4, stock: 2.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₁₈D₄N₅O₄.
Procainamide Hydrochloride, CAS: 614-39-1, stock: 3.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₂ClN₃O.
Procarbazine Hydrochloride, CAS: 366-70-1, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀ClN₃O.
Propyl 4-Bromo-2-fluorobenzamide, CAS: 1016811-41-8, stock: 4.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁NOFBr.
Propyzamide, CAS: 23950-58-5, stock: 1.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁Cl₂NO.
Quin C1, CAS: 786706-21-6, stock: 5.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₇N₃O₄.
R (+)-Eticlopride, CAS: 84226-12-0, stock: 8.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₅ClN₂O₃.
R-(-)-Flecainide, CAS: 99495-90-6, stock: 8.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀F₆N₂O₃.
R-Amisulpride, CAS: 71675-90-6, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₇N₃O₄S.
rac 4-(3’-Methoxy-α-chlorobenzyl)-N,N-diethylbenzamide, CAS: 186094-10-0, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂ClNO₂.
rac cis-3-Hydroxy Glyburide, CAS: 23074-02-4, stock: 8.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈ClN₃O₆S.
rac cis-3-Hydroxy Glyburide-13C,d3, CAS: 1217848-91-3, stock: 5.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂¹³CH₂₅D₃ClN₃O₆S.
rac cis-4-Hydroxy Glyburide, CAS: 132054-81-0, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈ClN₃O₆S.
rac erythro-3-(4-Nitrobenzamido)nonan-2-ol, CAS: 119691-06-4, stock: 8.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₄N₂O₄.
rac Indapamide, CAS: 26807-65-8, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆ClN₃O₃S.
rac Indapamide-d3, CAS: 1217052-38-4, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃D₃ClN₃O₃S.
rac Indapamide-N-(sulfonamido) Sulfate Disodium Salt, CAS: /, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄ClN₃Na₂O₆S₂.
rac N-Ethyl-N-(1-(3-(trifluoromethyl)phenyl)propan-2-yl)benzamide, CAS: /, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀F₃NO.
rac N-[4-Chloro-2-[3-cyclopropyl-1-hydroxy-1-(trifluoromethyl)-2-propynyl]phenyl]-4-methoxybenzamide, CAS: 1189491-03-9, stock: 6.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₇ClF₃NO₃.
rac Sulpiride, CAS: 15676-16-1, stock: 6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃N₃O₄S.
rac trans-2-Hydroxy Glyburide, CAS: 586414-93-9, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈ClN₃O₆S.
rac trans-3-Hydroxy Glyburide, CAS: 586414-84-8, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈ClN₃O₆S.
rac trans-4-Hydroxy Glyburide, CAS: 23155-00-2, stock: 3.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈ClN₃O₆S.
rac trans-4-Hydroxy Glyburide-13C,d3, CAS: 1217639-30-9, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂¹³CH₂₅D₃ClN₃O₆S.
rac Xanthoanthrafil (>90%), CAS: 1020251-53-9, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃N₃O₆.
rac Xanthoanthrafil-d3, CAS: 1216710-83-6, stock: 9.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀D₃N₃O₆.
rac-1,3-Dihydroxy-1-(3-nitrophenyl)propan-2-yl)benzamide, CAS: /, stock: 3.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆N₂O₅.
rac-2-Hydroxy-5-(1-hydroxyacetyl) Benzamide, CAS: /, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁NO₃.
rac-4-(3’-Methoxy-α-hydroxybenzyl)-N,N-diethylbenzamide, CAS: 186094-06-4, stock: 3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃NO₃.
rac-CCT 250863, CAS: 1364269-06-6, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅F₃N₄O₂S.
rac-cis-[3-Benzoyloxycyclohexyl]benzamide, CAS: 1346599-52-7, stock: 3.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁NO₃.
rac-cis-[3-Hydroxycyclohexyl]benzamide, CAS: 177366-89-1, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇NO₂.
rac-Keto Labetalol, CAS: 85665-85-6, stock: 8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂N₂O₃.
rac-Keto Labetalol Hydrochloride, CAS: 96441-14-4, stock: 9.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃ClN₂O₃.
rac-Monepantel, CAS: 851976-50-6, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₃F₆N₃O₂S.
rac-Monepantel Sulfone, CAS: 851976-52-8, stock: 8.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₃F₆N₃O₄S.
rac-PD-325901-d5, CAS: /, stock: 6.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₉D₅F₃IN₂O₄.
rac-trans-[3-Hydroxycyclohexyl]benzamide, CAS: 177366-90-4, stock: 2.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇NO₂.
Raclopride, CAS: 84225-95-6, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀Cl₂N₂O₃.
Raclopride Hydrochloride, CAS: 98527-32-3, stock: 3.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁Cl₃N₂O₃.
Raclopride-d5 Hydrochloride, CAS: 1217623-85-2, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆D₅Cl₃N₂O₃.
Radotinib, CAS: 926037-48-1, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₁F₃N₈O.
Rafoxanide, CAS: 22662-39-1, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₁Cl₂I₂NO₃.
Rafoxanide-13C6, CAS: 1353867-98-7, stock: 5.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃¹³C₆H₁₁Cl₂I₂NO₃.
RGFP 109, CAS: 1215493-56-3, stock: 1.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅N₃O₂.
Rhodamine 6G Bis(aminoethyl)amine Amide Bis (Trifluoroacetate), CAS: 1173097-37-4, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₇N₅O₂ • 2(C ₂HF₃O₂).
Rhodamine 6G bis(oxyethylamino)ethane Amide Bis (Trifluoroacetate), CAS: 1173097-69-2, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₀N₄O₄ • 2(C ₂HF₃O₂).
Rimeporide Hydrochloride, CAS: 187870-95-7, stock: 3.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆ClN₃O₅S₂.
Rimeporide-15N3 Hydrochloride, CAS: /, stock: 9.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆Cl¹⁵N₃O₅S₂.
RN 9893 Hydrochloride, CAS: 2109450-40-8, stock: 2.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₃F₃N₄O₅S • HCl.
RN-18, CAS: 431980-38-0, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₆N₂O₄S.
Ro3280, CAS: 1062243-51-9, stock: 4.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₅F₂N₇O₃.
Roflumilast, CAS: 162401-32-3, stock: 3.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄Cl₂F₂N₂O₃.
Roflumilast N-Oxide, CAS: 292135-78-5, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄Cl₂F₂N₂O₄.
Roflumilast-d4, CAS: 1398065-69-4, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₀D₄Cl₂F₂N₂O₃.
Roflumilast-d4 N-Oxide, CAS: 1794760-31-8, stock: 7.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₀D₄Cl₂F₂N₂O₄.
RSC 133, CAS: 1418131-46-0, stock: 6.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅N₃O₂.
S 14506 Hydrochloride, CAS: 286369-38-8, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₆FN₃O₂ • HCl.
S(-)-BZM Hydrochloride, CAS: 132448-73-8, stock: 1.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃ClN₂O₃.
S(-)-Raclopride (+)-Tartrate Salt, CAS: 98185-20-7, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀Cl₂N₂O₃ • C ₄H₆O₆.
S-(+)-Flecainide, CAS: 99495-92-8, stock: 4.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀F₆N₂O₃.
S-(+)-O-Desmethylraclopride Hydrobromide, CAS: 113310-88-6, stock: 8.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈Cl₂N₂O₃ •HBr.
S-(-)-Sulpiride, CAS: 23672-07-3, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃N₃O₄S.
S-(-)-Sulpiride-d3, CAS: 124020-27-5, stock: 6.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀D₃N₃O₄S.
S-3448, CAS: 254877-04-8, stock: 7.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆ClN₃O₇S₃.
S-Amisulpride, CAS: 71675-92-8, stock: 1.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₇N₃O₄S.
S-Desethyl S-Methyl Amisulpride, CAS: 71676-00-1, stock: 1.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅N₃O₄S.
S-Desethyl S-Methyl Amisulpride-d5, CAS: /, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀D₅N₃O₄S.
S-[2-(4-Azidosalicylamido)ethylthio]-2-thiopyridine, CAS: 164575-82-0, stock: 1.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃N₅O₂S₂.
S-[2-(Iodo-4-Azidosalicylamido)ethylthio]-2-thiopyridine, CAS: 175093-14-8, stock: 4.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁I₂N₅O₂S₂.
Saflufenacil, CAS: 372137-35-4, stock: 9.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇ClF₄N₄O₅S.
Saflufenacil-d7, CAS: /, stock: 7.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₀D₇ClF₄N₄O₅S.
Salicylamide, CAS: 65-45-2, stock: 7.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇NO₂.
Salicylanilide, CAS: 87-17-2, stock: 4.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁NO₂.
Salicylohydroxamic Acid, CAS: 89-73-6, stock: 3.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇NO₃.
SANT-2, CAS: 329196-48-7, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₆ClN₃O₄.
SB 268262, CAS: 217438-17-0, stock: 9.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅N₃O₄S₂.
SB 431542, CAS: 301836-41-9, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₆N₄O₃.
SB 743921 Hydrochloride, CAS: 940929-33-9, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₃ClN₂O₃ • HCl.
SBI-0206965, CAS: /, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁BrN₄O₅.
SC-53116 Hydrochloride Hydrate, CAS: 879208-42-1, stock: 8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃Cl₂N₃O₂ • xH ₂O.
Sch 527123, CAS: 473727-83-2, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₃N₃O₅.
Selonsertib, CAS: 1448428-04-3, stock: 5.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₄FN₇O.
Selonsertib Isopropyl-d7, CAS: /, stock: 8.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₇D₇FN₇O.
Sematilide Hydrochloride, CAS: 101526-62-9, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃N₃O₃S • (HCl).
SGI-1027, CAS: 1020149-73-8, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₃N₇O.
SH5-07, CAS: 1456632-41-9, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₈F₅N₃O₅S.
Sirtinol, CAS: 410536-97-9, stock: 2.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₂N₂O₂.
SNC 162, CAS: 178803-51-5, stock: 3.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₇N₃O.
SNC 80, CAS: 156727-74-1, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₉N₃O₂.
SNX-2112, CAS: 908112-43-6, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇F₃N₄O₃.
SR 0987, CAS: 303126-97-8, stock: 4.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₀ClF₆NO₂.
SR 1078, CAS: 1246525-60-9, stock: 8.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₀F₉NO₂.
SR 16832, CAS: 2088135-12-8, stock: 2.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂ClN₃O₄.
SR 3576, CAS: 1164153-22-3, stock: 9.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₇N₅O₅.
SRT 1460 Trifluoroacetic Acid Salt, CAS: /, stock: 1.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉N₅O₄S • x(C ₂HF₃O₂).
SRT 1460-d9, CAS: /, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₀D₉N₅O₄S.
Stauprimide, CAS: 154589-96-5, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₂₈N₄O₅.
Stauprimide-d5, CAS: 154589-96-5, stock: 2.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₂₃D₅N₄O₅.
STF 31, CAS: 724741-75-7, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₅N₃O₃S.
STF-118804, CAS: 894187-61-2, stock: 6.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₃N₃O₄S.
Sulclamide, CAS: 2455-92-7, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇ClN₂O₃S.
Sulfabenzamide, CAS: 127-71-9, stock: 8.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂N₂O₃S.
Sulfabenzamide-d4, CAS: /, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈D₄N₂O₃S.
Sulfosulfuron, CAS: 141776-32-1, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈N₆O₇S₂.
Sultopride Hydrochloride, CAS: 23694-17-9, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₇ClN₂O₄S.
Sultopride-d5, CAS: 1185004-43-6, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁D₅N₂O₄S.
SUN 11602, CAS: 704869-38-5, stock: 10g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₇N₅O₂.
t-Butyl 3-Bromo-4-fluorobenzamide, CAS: 1033201-68-1, stock: 2.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃BrFNO.
t-Butyl 5-bromo-2-chlorobenzamide, CAS: 892018-58-5, stock: 2.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃BrClNO.
T4-Formic Acid-N-methylamide, CAS: 2088032-78-2, stock: 8.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₉I₄NO₃.
Tacedinaline, CAS: 112522-64-2, stock: 6.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅N₃O₂.
TAK 715, CAS: 303162-79-0, stock: 7.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁N₃OS.
TAK 960 Hydrochloride, CAS: 1137868-96-2, stock: 1.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₄F₃N₇O₃ • HCl.
TAK-960, CAS: 1137868-52-0, stock: 5.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CH₃₄F₃N₇O₃.
TAK-960-d3, CAS: /, stock: 4.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CH₃₁D₃F₃N₇O₃.
Takeda 103A, CAS: 865609-72-9, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃F₂N₇O.
Tasisulam, CAS: 519055-62-0, stock: 5.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₆BrCl₂NO₃S₂.
TC ASK 10, CAS: 1005775-56-3, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₃Cl₂N₅O.
TC Mps1 12, CAS: 1206170-62-8, stock: 9.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀N₆O.
TC-S 7010, CAS: 1158838-45-9, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₁ClFN₇O₂.
Tecovirimat, CAS: 869572-92-9, stock: 3.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₅F₃N₂O₃.
Teflubenzuron, CAS: 83121-18-0, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₆Cl₂F₄N₂O₂.
Teflubenzuron-d3, CAS: /, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₃D₃Cl₂F₄N₂O₂.
Teijin Compound 1, CAS: 1313730-14-1, stock: 1.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁ClF₃N₃O₂ • HCl.
Tenovin 1, CAS: 380315-80-0, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃N₃O₂S.
Tenovin 6 Hydrochloride, CAS: 1011557-82-6, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄N₄O₂S .HCl.
tert-Butyl (4R,5R)-4-(Hydroxymethyl)-2,2-dimethyl-5-phenyl-1,3-oxazolidine-3-carboxylate, CAS: 1009092-91-4, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₅NO₄.
tert-Butyl 3-Ethyl-4-oxopiperidine-1-carboxylate, CAS: 117565-57-8, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₁NO₃.
Tetrahydro-2,2,6,6-tetramethyl-2H-pyran-4-amine, CAS: 1301178-43-7, stock: 4.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₉NO.
TG53, CAS: 946369-04-6, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂ClN₅O₂.
Thiobenzamide, CAS: 2227-79-4, stock: 1.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇NS.
THZ1, CAS: 1604810-83-4, stock: 8.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₂₈ClN₇O₂.
THZ1-d6, CAS: /, stock: 6.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₂₂D₆ClN₇O₂.
Tiapride, CAS: 51012-32-9, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₄N₂O₄S.
Tiapride Hydrochloride, CAS: 51012-33-0, stock: 10g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅ClN₂O₄S.
Tinisulpride Hydrochloride, CAS: 69387-88-8, stock: 10g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₉N₃O₄S•HCl.
Tizoxanide, CAS: 173903-47-4, stock: 8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇N₃O₄S.
Tizoxanide Sulfate, CAS: 1391053-06-7, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇N₃O₇S₂.
Tizoxanide-d4, CAS: 1246817-56-0, stock: 7.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₃D₄N₃O₄S.
TMN 355, CAS: 1186372-20-2, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₄ClFN₂O₂.
TMP269, CAS: 1314890-29-3, stock: 9.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₁F₃N₄O₃S.
Tolvaptan, CAS: 150683-30-0, stock: 1.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₅ClN₂O₃.
Tolvaptan-d7, CAS: 1246818-18-7, stock: 8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₁₈D₇ClN₂O₃.
trans-3,4-Dibromo-N-methyl-N-(1-methyl-1-azaspiro[4.5]dec-6-yl)-benzamide, CAS: 119878-31-8, stock: 9.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄Br₂N₂O.
---, CAS: ---, stock: 8.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ---.
trans-Nemonapride, CAS: 752154-64-6, stock: 5.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆ClN₃O₂.
Tretazicar (>94%), CAS: 21919-05-1, stock: 5.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈N₄O₅.
Triflumuron, CAS: 64628-44-0, stock: 7.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀ClF₃N₂O₃.
Trimethobenzamide Hydrochloride, CAS: 554-92-7, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₉ClN₂O₅.
Tripamide, CAS: 73803-48-2, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀ClN₃O₃S.
Tripamide-d4, CAS: /, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆D₄ClN₃O₃S.
Tubastatin A Hydrochloride, CAS: 1310693-92-5, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₂ClN₃O₂.
Tubastatin A Hydrochloride, CAS: 1310693-92-5, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁N₃O₂ • HCl.
Tubastatin A Trifluoroacetic Acid Salt, CAS: 1239262-52-2, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂F₃N₃O₄.
TW-37, CAS: 877877-35-5, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₅NO₆S.
U 47700, CAS: 82657-23-6, stock: 6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂Cl₂N₂O.
U 47700-d6, CAS: /, stock: 5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆D₆Cl₂N₂O.
U 4793e, CAS: 67579-24-2, stock: 2.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁BrN₂O.
U-49900, CAS: 67579-76-4, stock: 2.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₆Cl₂N₂O.
U-54494A Hydrochloride, CAS: 112465-94-8, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄Cl₂N₂O •HCl.
UNC 1215, CAS: 1415800-43-9, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₃N₅O₂.
VEGFR Tyrosine Kinase Inhibitor II, CAS: 269390-69-4, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆ClN₃O.
Venetoclax Positional Isomer, CAS: /, stock: 3.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₅₀ClN₇O₇S.
Venetoclax-d6, CAS: /, stock: 8.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₄₄D₆ClN₇O₇S.
Venetoclax-M27, CAS: 2097938-69-5, stock: 1.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
VER-246608, CAS: 1684386-71-7, stock: 3.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₃ClF₂N₄O₄.
Veralipride, CAS: 66644-81-3, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₅N₃O₅S.
Veralipride-d6, CAS: 105258-80-8, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉D₆N₃O₅S.
Vismodegib, CAS: 879085-55-9, stock: 3.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄Cl₂N₂O₃S.
Vismodegib-d4, CAS: 1450990-33-6, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₀D₄Cl₂N₂O₃S.
Volasertib, CAS: 755038-65-4, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₅₀N₈O₃.
Volasertib-D3, CAS: /, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₄₇D₃N₈O₃.
VU 0357121, CAS: 433967-28-3, stock: 8.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇F₂NO₂.
VU 0409106, CAS: 1276617-62-9, stock: 1.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁FN₄O₂S.
Xipamide, CAS: 14293-44-8, stock: 5.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅ClN₂O₄S.
Xipamide-d6, CAS: 1330262-09-3, stock: 3.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉D₆ClN₂O₄S.
XL765, CAS: 1349796-36-6, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₂₉N₅O₆S.
Y-39983 Hydrochloride, CAS: 173897-44-4, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆N₄O • 2HCl.
YM 758 Phosphate, CAS: 312752-86-6, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₅FN₃O₈P.
YU 238259, CAS: 1943733-16-1, stock: 4.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂ClN₃O₄S.
Zacopride, CAS: 90182-92-6, stock: 8.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀ClN₃O₂.
Zacopride Hydrochloride, CAS: 101303-98-4, stock: 5.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀ClN₃O₂ • HCl.
Zafirlukast M1 Metabolite, CAS: 219583-10-5, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₅N₃O₄S.
ZM 336372, CAS: 208260-29-1, stock: 5.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₃N₃O₃.
ZM 447439, CAS: 331771-20-1, stock: 8.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₁N₅O₄.
Zoalene, CAS: 148-01-6, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇N₃O₅.
Zoxamide, CAS: 156052-68-5, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₆Cl₃NO₂.
Zoxamide-d5, CAS: 1794760-54-5, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁D₅Cl₃NO₂.
[2-[[4-(Aminomethyl)benzoyl]amino]phenyl]-carbamic Acid tert-Butyl Ester, CAS: 209784-85-0, stock: 7.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃N₃O₃.
[4-(Difluoromethoxy)phenyl]hydrazine Hydrochloride, CAS: 1240527-90-5, stock: 7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉ClF₂N₂O.
[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]boronic Acid, CAS: 763120-62-3, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉BN₂O₂.
[R-(R*,R*)]-5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)(phenylmethyl)amino]ethyl]-2-(phenylmethoxy)benzamide, CAS: 75615-55-3, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₆N₂O₃.
[R-(R*,R*)]-5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)(phenylmethyl)amino]ethyl]-2-(phenylmethoxy)benzamide-d3, CAS: /, stock: 4.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₃D₃N₂O₃.
[S-(R*,S*)]-5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)(phenylmethyl)amino]ethyl]-2-(phenylmethoxy)benzamide, CAS: 81580-37-2, stock: 4.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₆N₂O₃.
[S-(R*,S*)]-5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)(phenylmethyl)amino]ethyl]-2-(phenylmethoxy)benzamide-d3, CAS: /, stock: 1.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₃D₃N₂O₃.
